Literature DB >> 2881518

Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.

J Roquebert, B Grenié.   

Abstract

The effect of ergotamine and dihydroergotamine on peripheral alpha-adrenoceptors was examined in pithed rats. The pressor response to ergot alkaloids was reduced competitively by yohimbine but not by prazosin or methysergide. These results show that the vasoconstriction induced by ergot alkaloids is mediated by alpha 2-adrenoceptors. Ergot alkaloids decreased the tachycardia elicited by stimulation of the cardioaccelerator sympathetic nerves, this effect being antagonized by yohimbine. The pressor response to (-)-phenylephrine was reduced by ergot alkaloids, suggesting competitive antagonism. It is suggested that in the pithed rat both ergotamine and dihydroergotamine act at the periphery as competitive alpha 1-adrenoceptor blockers and partial alpha 2-adrenoceptor agonists.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2881518

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  8 in total

1.  Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.

Authors:  M O den Boer; J P Heiligers; P R Saxena
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

2.  Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain.

Authors:  N Hanoun; F Saurini; L Lanfumey; M Hamon; S Bourgoin
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

3.  Involvement of signaling pathways in bovine sperm motility, and effect of ergot alkaloids.

Authors:  Hehai Wang; Michael L Looper; Zelpha B Johnson; Rick W Rorie; Charles F Rosenkrans
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-05-19       Impact factor: 2.416

4.  Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors.

Authors:  A H Bom; J P Heiligers; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

5.  Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.

Authors:  Luis E Cobos-Puc; Carlos M Villalón; Araceli Sánchez-López; Martha B Ramírez-Rosas; Jair Lozano-Cuenca; Heinz H Pertz; Tilo Görnemann; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-09-09       Impact factor: 3.000

6.  Vasoactive Effects of Acute Ergot Exposure in Sheep.

Authors:  Rossalin Yonpiam; Jair Gobbet; Ashok Jadhav; Kaushik Desai; Barry Blakley; Ahmad Al-Dissi
Journal:  Toxins (Basel)       Date:  2021-04-20       Impact factor: 4.546

7.  The role of α1- and α2-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats.

Authors:  Eduardo Rivera-Mancilla; Victor H Avilés-Rosas; Guadalupe Manrique-Maldonado; Alain H Altamirano-Espinoza; Belinda Villanueva-Castillo; Antoinette MaassenVanDenBrink; Carlos M Villalón
Journal:  J Headache Pain       Date:  2017-10-11       Impact factor: 7.277

8.  Arterial Responses to Acute Low-Level Ergot Exposure in Hereford Cows.

Authors:  Vanessa Elizabeth Cowan; Alex Neumann; John McKinnon; Barry Raymond Blakley; Taylor Jayne Grusie; Jaswant Singh
Journal:  Front Vet Sci       Date:  2018-10-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.